Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Diabetes Intervention
As a complex metabolic disease, diabetes does not lend itself to a wide variety of interventions and concurring the disease does not appear to be an event that medicine will see in the near horizon. For these reasons, and because diabetes can be such a devastating disease, research that shows promise of positively impacting the course of the disease is greeted with enthusiasm by the medical community and the public.
Blood glucose levels must be strictly regulated in order to avoid the complications that diabetes can create. A substantive stumbling block is the difficulty of achieving consistent glycemic control without occurrences of hypoglycemia. Indeed, this factor is a primary obstacle to obtaining regulatory approval of an artificial pancreas. Earlier research has focused on automatic systems that monitor the levels of glucose and stop insulin flow when the blood glucose drops too low. While this is a viable approach, it can only limit -- but not eliminate -- the impact of hypoglycemia. Dr. Steven Russell at Massachusetts General Hospital is taking another tack: his research focuses on automated systems that use glucagon to prevent hypoglycemia. The systems Russell is developing combine closed-loop glucagon and closed-loop insulin delivery -- in effect, the Russell system functions as a bionic pancreas.
The...
(2014) are conducting a line of research that is receiving considerable attention: automated glycemic management through the use of an automated, wearable "bionic" pancreas. The effectiveness and safety of this type of system has just recently been subjected to multiday, random-order, crossover studies. Russell, et al. (2014) developed and compared two interventions: 1) Glycemic control with a wearable, bihormonal, automated, "bionic" pancreas; and, 2)glycemic control with an insulin pump. Over a period of five days, 20 adults and 32 adolescents with type 1 diabetes mellitus participated in the study. The bionic pancreas automatically adapted to the stream of continuous data sent by the glucose monitor in order to control the appropriate delivery of subcutaneous glucagon and insulin.
Results
The wearable, automated, biohormonal, bionic pancreas was found to improve the mean glycemic levels in both the adults and the adolescents with type 1 diabetes mellitus. In addition, there were less frequency hypoglycemic episodes than occurred with the insulin pump. The specific results for the comparison, which are shown separately for the adults and the adolescents, study follow.
Findings for adults. "[T]he mean plasma glucose level over the 5-day bionic-pancreas period was 138 mg per…
References
Progress in artificial pancreas development: preventing and treating low blood glucose. (2014, September 11). American Diabetes Association. ADA-Novo Nordisk Award in Hypoglycemia and Diabetes. Supported by Novo Nordisk Inc. Retreived from http://www.diabetes.org/research-and-practice/we-are-research-leaders/recent-advances/progress-in-artificial-pancreas-development.html#sthash.HZwOqdlx.dpuf
Russell, S.J., El-Khatib, F.H., Sinha, M., Magyar, K.L., McKeon, K., Goergen, L.G., Balliero, C., Hillard, M.A., Nathan, D.M., & Damiano, E.R. (2014, July 24). Outpatient glycemic control with a bionic pancreas in type 1 diabetes. New England Journal of Medicine. 371(4), 313-25. doi: 10.1056/NEJMoa1314474. Epub 2014 Jun 15.
Once a participant is suspected of having diabetes, through the use of this survey, they may choose to contact one of the related agencies, where information and support would be offered. National Diabetes Awareness Month, promoted and sponsored by MMWR, was held in November of 2006, and was a program similar to the one which is being proposed by this group of organizations (See http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5543a1.htm). The program published reports throughout
Problem Statement and Purpose of Study Self-care regimens that require a lot of input are necessary in making the study of diabetes effective. A lot of people with diabetes undergo distress. The diabetes distress is commonly described as the distress that arises from the effect of the diabetes symptoms, regimens for self management, the fear that there would be complications and functionality failure. The diabetes stress stabilizes after some time.
Critique The article by Lynch et al. (2019) is entitled “Randomized Trial of a Lifestyle Intervention for Urban Low-Income African Americans with Type 2 Diabetes” and appeared in JGIM: Journal of General Internal Medicine. The article by Protheroe et al. (2016) is entitled “The Feasibility of Health Trainer Improved Patient Self-Management in Patients with Low Health Literacy and Poorly Controlled Diabetes: A Pilot Randomised Controlled Trial” and appeared in Journal of
Diabetes Evidence-Based Practice Diabetes Diabetes is a disease which stays with the patient life-long except in some cases where the diabetes is gestational which occurs during pregnancy and often goes back to normal after the delivery. Typically there are two types of diabetes which are type 1 and type 2 diabetes but less common are gestational diabetes and other types which contain features of both type 1 and type 2 diabetes (Cowle
Researchers used this information, and designed it in such a way that it fit in with the lifestyle that this population was accustomed to (Acton, Shields, Rith-Najarian, Tolbert, Kelly, Moore, Valdez, Skipper, & Gohdes, 2001). This allowed the researchers not only to study the population more closely, but also to achieve a major degree of success that might not have been possible in a standard intervention program. The study found
Diabetes Education What is Diabetes? Interventions Management Self-Care Diabetes Education Clinical Practice Recommendations Diabetes Education Diabetes is considered to be a chronic disease which really needs some kind of long-term nursing and medical intermediations. Research shows that patients likewise need to take a part that is active in their own treatment and management, and the alter their lifestyles in order to keep their metabolic state at a level that is normal (Sperl-Hillen, 2010). One of the transformations in